Option awards adjusted for Kamada (KMDA) director after cash dividend
Rhea-AI Filing Summary
Kamada Ltd director Leon Recanati reported a series of administrative transactions in employee stock options held indirectly through a trustee under the company’s 2011 Share Award Plan. On April 7, 2026, he received multiple option grants (code A) and simultaneously returned matching options to the issuer (code D) with slightly different exercise prices.
Footnotes explain that exercise prices in U.S. dollars are convenience translations from NIS and were adjusted under the plan following a cash dividend declared on March 11, 2026, with no other changes to the awards’ terms. The options vest in four equal annual installments, and there were no open‑market purchases or sales of ordinary shares disclosed.
Positive
- None.
Negative
- None.
Insights
Routine option price adjustments tied to a dividend, with no net new exposure.
This filing shows Leon Recanati, a director of Kamada Ltd, engaging in paired acquisitions (code A) and dispositions to the issuer (code D) of employee stock options, all held indirectly by a trustee under the 2011 Share Award Plan. Each grant is mirrored by a cancellation of the same number of options.
Footnotes state that exercise prices, such as $7.23 and $5.87 per share, were adjusted under the plan after a cash dividend declared on March 11, 2026, and converted from NIS into U.S. dollars for convenience. The underlying options continue to vest 25% annually on each of four anniversaries of the grant date.
No common shares were bought or sold in the market, and the transaction summary shows neutral net buy/sell direction. From an investor perspective, this appears to be a technical repricing adjustment following a dividend rather than a change in the director’s economic exposure, so the overall impact is neutral.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 6,625 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Disposition | Employee Stock Option (right to buy) | 7,500 | $0.00 | -- |
Footnotes (1)
- All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan.